New and Generic Drug Approvals
August 30, 2014
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Avastin | bevacizumab | Vial; Intravenous | Genentech | Labeling Revision |
| Vectibix | panitumumab | Injectable; Iv (Infusion) | Amgen | Labeling Revision |
| Vimpat | lacosamide | Tablet;Oral | Ucb Inc | Efficacy Supplement with Clinical Data to Support |
| Vimpat | lacosamide | Solution;Intravenous | Ucb Inc | Efficacy Supplement with Clinical Data to Support |
| Vimpat | lacosamide | Solution;Oral | Ucb Inc | Efficacy Supplement with Clinical Data to Support |
No comments:
Post a Comment